FXS VENTURES LLC has a total of 49 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets basic materials chemistry, medical technology and pharmaceuticals are ASEPTIX RES B V, SMITH FRANCIS X and NOVAPHARM RES AUSTRALIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Australia | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Japan | 3 |
# | Industry | |
---|---|---|
#1 | Basic materials chemistry | |
#2 | Medical technology | |
#3 | Pharmaceuticals | |
#4 | Optics | |
#5 | Consumer goods | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Preservation of human bodies | |
#3 | Medical preparations | |
#4 | Soaps | |
#5 | Therapeutic chemical compounds | |
#6 | Optical systems | |
#7 | Hand carried bags | |
#8 | Coating compositions | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Smith Francis X | 34 |
#2 | Smith Francis Xavier | 15 |
#3 | Tracey John Randall | 1 |
#4 | Crawford Kathryn S | 1 |
Publication | Filing date | Title |
---|---|---|
US2020289699A1 | L-histidine and vitamin b in ophthalmic solutions | |
US2017013839A1 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers | |
US2013079422A1 | Ophthalmic contact lens solutions containing forms of vitamin B | |
US2007104744A1 | Ophthalmic and contact lens solutions containing forms of vitamin b | |
US2007098813A1 | Ophthalmic and contact lens solutions with a peroxide source and a preservative | |
US2007110782A1 | L-histidine in ophthalmic solutions | |
AU2006230656A1 | Improved Ophthalmic and Contact Lens Solutions Containing Forms of Vitamin B | |
US7678836B2 | Method for rendering a contact lens wettable | |
WO2004091438A2 | Improved ophthalmic and contact lens solutions containing peptides as representative enhancers | |
US7067547B1 | Ophthalmic and contact lens solutions comprising imidazole |